- call +1-201-465-4211
- email sales@mrinsights.biz
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Scope of the Report:
The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.
The product is invented and first produced in the UK by AstraZeneca. AstraZeneca is also the leader of the Quetiapine Fumarate base drugs.
The Average gross of the industry is over 40%. However, since there are new companies coming into the area, the gross is declining in the last several years.
The worldwide market for Quetiapine Fumarate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Quetiapine Fumarate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immediate Release Tablets
Extended Release Tablets
Market Segment by Applications, can be divided into
Application I
Application II
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quetiapine Fumarate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Quetiapine Fumarate, with price, sales, revenue and global market share of Quetiapine Fumarate in 2017 and 2018.
Chapter 3, the Quetiapine Fumarate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quetiapine Fumarate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Quetiapine Fumarate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Quetiapine Fumarate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Quetiapine Fumarate Introduction
1.2 Market Analysis by Type
1.2.1 Immediate Release Tablets
1.2.2 Extended Release Tablets
1.3 Market Analysis by Applications
1.3.1 Application I
1.3.2 Application II
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Quetiapine Fumarate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Intas
2.2.1 Business Overview
2.2.2 Quetiapine Fumarate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Intas Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 TAPI
2.3.1 Business Overview
2.3.2 Quetiapine Fumarate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 TAPI Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Accord
2.4.1 Business Overview
2.4.2 Quetiapine Fumarate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Accord Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hexal
2.5.1 Business Overview
2.5.2 Quetiapine Fumarate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hexal Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dr.Reddy's
2.6.1 Business Overview
2.6.2 Quetiapine Fumarate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Lupin
2.7.1 Business Overview
2.7.2 Quetiapine Fumarate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Lupin Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sun Pharmaceutical
2.8.1 Business Overview
2.8.2 Quetiapine Fumarate Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Hunan Dongting Pharm
2.9.1 Business Overview
2.9.2 Quetiapine Fumarate Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 SuZhou NO.4 Phamaceutical Factory
2.10.1 Business Overview
2.10.2 Quetiapine Fumarate Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Fuan Pharmaceutical
2.11.1 Business Overview
2.11.2 Quetiapine Fumarate Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Zhejiang Supor Pharmaceuticals
2.12.1 Business Overview
2.12.2 Quetiapine Fumarate Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Zhejiang Huahai Pharmaceutical
2.13.1 Business Overview
2.13.2 Quetiapine Fumarate Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Quetiapine Fumarate Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Quetiapine Fumarate Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Quetiapine Fumarate Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Quetiapine Fumarate Manufacturer Market Share in 2018
3.3.2 Top 6 Quetiapine Fumarate Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Quetiapine Fumarate Market Analysis by Regions
4.1 Global Quetiapine Fumarate Sales, Revenue and Market Share by Regions
4.1.1 Global Quetiapine Fumarate Sales and Market Share by Regions (2014-2019)
4.1.2 Global Quetiapine Fumarate Revenue and Market Share by Regions (2014-2019)
4.2 North America Quetiapine Fumarate Sales and Growth Rate (2014-2019)
4.3 Europe Quetiapine Fumarate Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Quetiapine Fumarate Sales and Growth Rate (2014-2019)
4.5 South America Quetiapine Fumarate Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Quetiapine Fumarate Sales and Growth Rate (2014-2019)
5 North America Quetiapine Fumarate by Country
5.1 North America Quetiapine Fumarate Sales, Revenue and Market Share by Country
5.1.1 North America Quetiapine Fumarate Sales and Market Share by Country (2014-2019)
5.1.2 North America Quetiapine Fumarate Revenue and Market Share by Country (2014-2019)
5.2 United States Quetiapine Fumarate Sales and Growth Rate (2014-2019)
5.3 Canada Quetiapine Fumarate Sales and Growth Rate (2014-2019)
5.4 Mexico Quetiapine Fumarate Sales and Growth Rate (2014-2019)
6 Europe Quetiapine Fumarate by Country
6.1 Europe Quetiapine Fumarate Sales, Revenue and Market Share by Country
6.1.1 Europe Quetiapine Fumarate Sales and Market Share by Country (2014-2019)
6.1.2 Europe Quetiapine Fumarate Revenue and Market Share by Country (2014-2019)
6.2 Germany Quetiapine Fumarate Sales and Growth Rate (2014-2019)
6.3 UK Quetiapine Fumarate Sales and Growth Rate (2014-2019)
6.4 France Quetiapine Fumarate Sales and Growth Rate (2014-2019)
6.5 Russia Quetiapine Fumarate Sales and Growth Rate (2014-2019)
6.6 Italy Quetiapine Fumarate Sales and Growth Rate (2014-2019)
7 Asia-Pacific Quetiapine Fumarate by Country
7.1 Asia-Pacific Quetiapine Fumarate Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Quetiapine Fumarate Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Quetiapine Fumarate Revenue and Market Share by Country (2014-2019)
7.2 China Quetiapine Fumarate Sales and Growth Rate (2014-2019)
7.3 Japan Quetiapine Fumarate Sales and Growth Rate (2014-2019)
7.4 Korea Quetiapine Fumarate Sales and Growth Rate (2014-2019)
7.5 India Quetiapine Fumarate Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Quetiapine Fumarate Sales and Growth Rate (2014-2019)
8 South America Quetiapine Fumarate by Country
8.1 South America Quetiapine Fumarate Sales, Revenue and Market Share by Country
8.1.1 South America Quetiapine Fumarate Sales and Market Share by Country (2014-2019)
8.1.2 South America Quetiapine Fumarate Revenue and Market Share by Country (2014-2019)
8.2 Brazil Quetiapine Fumarate Sales and Growth Rate (2014-2019)
8.3 Argentina Quetiapine Fumarate Sales and Growth Rate (2014-2019)
8.4 Colombia Quetiapine Fumarate Sales and Growth Rate (2014-2019)
9 Middle East and Africa Quetiapine Fumarate by Countries
9.1 Middle East and Africa Quetiapine Fumarate Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Quetiapine Fumarate Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Quetiapine Fumarate Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Quetiapine Fumarate Sales and Growth Rate (2014-2019)
9.3 Turkey Quetiapine Fumarate Sales and Growth Rate (2014-2019)
9.4 Egypt Quetiapine Fumarate Sales and Growth Rate (2014-2019)
9.5 Nigeria Quetiapine Fumarate Sales and Growth Rate (2014-2019)
9.6 South Africa Quetiapine Fumarate Sales and Growth Rate (2014-2019)
10 Global Quetiapine Fumarate Market Segment by Type
10.1 Global Quetiapine Fumarate Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Quetiapine Fumarate Sales and Market Share by Type (2014-2019)
10.1.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2014-2019)
10.2 Immediate Release Tablets Sales Growth and Price
10.2.1 Global Immediate Release Tablets Sales Growth (2014-2019)
10.2.2 Global Immediate Release Tablets Price (2014-2019)
10.3 Extended Release Tablets Sales Growth and Price
10.3.1 Global Extended Release Tablets Sales Growth (2014-2019)
10.3.2 Global Extended Release Tablets Price (2014-2019)
11 Global Quetiapine Fumarate Market Segment by Application
11.1 Global Quetiapine Fumarate Sales Market Share by Application (2014-2019)
11.2 Application I Sales Growth (2014-2019)
11.3 Application II Sales Growth (2014-2019)
12 Quetiapine Fumarate Market Forecast (2019-2024)
12.1 Global Quetiapine Fumarate Sales, Revenue and Growth Rate (2019-2024)
12.2 Quetiapine Fumarate Market Forecast by Regions (2019-2024)
12.2.1 North America Quetiapine Fumarate Market Forecast (2019-2024)
12.2.2 Europe Quetiapine Fumarate Market Forecast (2019-2024)
12.2.3 Asia-Pacific Quetiapine Fumarate Market Forecast (2019-2024)
12.2.4 South America Quetiapine Fumarate Market Forecast (2019-2024)
12.2.5 Middle East and Africa Quetiapine Fumarate Market Forecast (2019-2024)
12.3 Quetiapine Fumarate Market Forecast by Type (2019-2024)
12.3.1 Global Quetiapine Fumarate Sales Forecast by Type (2019-2024)
12.3.2 Global Quetiapine Fumarate Market Share Forecast by Type (2019-2024)
12.4 Quetiapine Fumarate Market Forecast by Application (2019-2024)
12.4.1 Global Quetiapine Fumarate Sales Forecast by Application (2019-2024)
12.4.2 Global Quetiapine Fumarate Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Quetiapine Fumarate Picture
Table Product Specifications of Quetiapine Fumarate
Figure Global Sales Market Share of Quetiapine Fumarate by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
